Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine

被引：0
|
作者：
Marko Lucijanic
Cedna Tomasovic-Loncaric
Tajana Stoos-Veic
Tomislav De Both
Barbara Jalsenjak
Rajko Kusec
机构：
[1] University Hospital Dubrava,Hematology Department
[2] University of Zagreb,School of Medicine
[3] University Hospital Dubrava,Pathology and Cytology Department
[4] Catholic University of Croatia,Faculty of Medicine Osijek
[5] Josip Juraj Strossmayer University of Osijek,Urology Department
[6] University Hospital Dubrava,undefined
来源：
Annals of Hematology | 2024年 / 103卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：671 / 672
页数：1
相关论文
共 50 条
  • [1] Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine
    Lucijanic, Marko
    Tomasovic-Loncaric, Cedna
    Stoos-Veic, Tajana
    De Both, Tomislav
    Jalsenjak, Barbara
    Kusec, Rajko
    ANNALS OF HEMATOLOGY, 2024, 103 (02) : 671 - 672
  • [2] Venetoclax Combined with Azacitidine and Homoharringtonine in Adults with Secondary Acute Myeloid Leukemia
    Huang, Fei
    Chen, Yu
    Shi, Zhongxun
    Huang, Huijun
    Li, Jianyong
    Shen, Wenyi
    BLOOD, 2023, 142
  • [3] Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
    DiNardo, C. D.
    Jonas, B. A.
    Pullarkat, V.
    Thirman, M. J.
    Garcia, J. S.
    Wei, A. H.
    Konopleva, M.
    Doehner, H.
    Letai, A.
    Fenaux, P.
    Koller, E.
    Havelange, V.
    Leber, B.
    Esteve, J.
    Wang, J.
    Pejsa, V.
    Hajek, R.
    Porkka, K.
    Illes, A.
    Lavie, D.
    Lemoli, R. M.
    Yamamoto, K.
    Yoon, S. -S.
    Jang, J. -H.
    Yeh, S. -P.
    Turgut, M.
    Hong, W. -J.
    Zhou, Y.
    Potluri, J.
    Pratz, K. W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07): : 617 - 629
  • [4] Abbreviated venetoclax with decitabine or azacitidine in acute myeloid leukemia
    Bouligny, Ian M.
    Murray, Graeme
    Ho, Thuy
    Doyel, Michael
    Patel, Tilak
    Boron, Josh
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Alnimer, Yanal
    Zacholski, Kyle
    Venn, Chad
    Wages, Nolan A.
    Grant, Steven
    Maher, Keri R.
    LEUKEMIA RESEARCH, 2023, 134
  • [5] The impact of secondary-type mutations in newly diagnosed acute myeloid leukemia treated with venetoclax and decitabine or azacitidine
    Doyel, Michael
    Bouligny, Ian Michael
    Murray, Graeme
    Patel, Tilak
    Boron, Josh
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Thuy Ho
    Zacholski, Kyle
    Venn, Chad Michael
    Alnimer, Yanal Mufeed
    Wages, Nolan
    Grant, Steven
    Maher, Keri Renee
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Evaluation of Lymphocyte Immunity in Patients Treated with Venetoclax-Azacitidine for Acute Myeloid Leukemia
    Kanaya, Minoru
    Suzuki, Toma
    Kajikawa, Sayaka
    Yokoyama, Emi
    Izumiyama, Koh
    Saito, Makoto
    Morioka, Masanobu
    Mori, Akio
    Matsukawa, Toshihiro
    Onozawa, Masahiro
    Teshima, Takanori
    Kondo, Takeshi
    BLOOD, 2024, 144 : 6061 - 6062
  • [7] Measurable residual disease response in acute myeloid leukemia treated with venetoclax and azacitidine.
    Pratz, Keith
    Jonas, Brian Andrew
    Pullarkat, Vinod
    Recher, Christian
    Schuh, Andre C.
    Thirman, Michael J.
    Garcia, Jacqueline Suen
    Dinardo, Courtney Denton
    Vorobyev, Vladimir
    Fracchiolla, Nicola
    Yeh, Su-Peng
    Jang, Jun Ho
    Ozcan, Muhit
    Yamamoto, Kazuhito
    Illes, Arpad
    Zhou, Ying
    Dail, Monique
    Chyla, Brenda
    Potluri, Jalaja
    Dohner, Hartmut
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Favorable Radiographic Response in a Patient With an Oligodendroglioma Treated With Azacitidine and Venetoclax for Acute Myeloid Leukemia
    Perez, Mauricio
    Barrionuevo, Vanessa
    Arias, Cristina
    Baehring, Joachim M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [9] Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia
    Bouligny I.M.
    Murray G.
    Doyel M.
    Patel T.
    Boron J.
    Tran V.
    Gor J.
    Hang Y.
    Alnimer Y.
    Ho T.
    Zacholski K.
    Venn C.
    Wages N.A.
    Grant S.
    Maher K.R.
    Medical Oncology, 41 (3)
  • [10] Acute onset urinary retention and neurogenic bladder: an unusual presenting feature of childhood acute myeloid leukemia
    Panda, Prateek Kumar
    Sharawat, Indar Kumar
    Tomar, Apurva
    Arya, Shubhangee
    Chetia, Rituparna
    Sherwani, Poonam
    ACTA NEUROLOGICA BELGICA, 2022, 122 (03) : 813 - 816
12345